TIDMAPAX
RNS Number : 9095N
Apax Global Alpha Limited
01 November 2016
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR
INDIRECTLY, IN WHOLE OR IN PART, INTO OR WITHIN THE UNITED STATES
OR TO "US PERSONS" (AS DEFINED IN REGULATION S UNDER THE UNITED
STATES SECURITIES ACT OF 1933, AS AMED (THE "SECURITIES ACT")) OR
INTO OR WITHIN AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN. RECIPIENTS
OF THIS ANNOUNCEMENT IN JURISDICTIONS OUTSIDE THE UK SHOULD INFORM
THEMSELVES ABOUT AND OBSERVE ANY APPLICABLE LEGAL REQUIREMENTS IN
THEIR JURISDICTIONS. IN PARTICULAR, THE DISTRIBUTION OF THE
ANNOUNCEMENT MAY BE RESTRICTED BY LAW IN CERTAIN JURISDICTIONS.
Note that references in this announcement to Apax Global Alpha
Limited have been abbreviated to "AGA" or "the Company". References
to Apax Partners LLP have been abbreviated to "Apax Partners" or
"the Investment Adviser"
FOR IMMEDIATE RELEASE
1 November 2016
(LSE: APAX)
Apax Global Alpha Limited
Quarterly Results for the period ended 30 September 2016
For further information regarding the announcement of AGA's Q3
2016 results, including the details for today's analyst and
investor conference call at 9.30am (UK time), please visit
www.apaxglobalalpha.com/shareholder-information/calendar
Financial highlights for the three months to 30 September
2016
-- Adjusted NAV slightly down at EUR889.6m compared to EUR894.4m
at 30 June 2016 mainly due to semi-annual dividend paid in the
quarter of EUR22.4m
-- Adjusted NAV per share of EUR1.81 (GBP1.57) after a dividend
of 4.59 euro cents (3.95 pence sterling) per share compared to
EUR1.82 (GBP1.52) at 30 June 2016
-- Total Return in Q3 was 2.0%. On a constant currency basis it
was 2.6% reflecting the appreciation of the euro against the US
dollar and sterling.
-- AGA was 93% invested and had a cash balance of EUR65.6m as at quarter end
Investment highlights for the three months to 30 September
2016
-- Well-balanced invested portfolio: Private Equity (51%) and Derived Investments (49%)
-- Sector exposure spread across all Apax Partners' focus
industries. Tech & Telco was the most heavily weighted sector,
accounting for 38% of the invested portfolio
-- Geographic bias towards North America, representing 57% of the invested portfolio
Performance
-- Portfolio performance improved for the three months to 30
September 2016 driven mainly by income and unrealised gains in
Derived Investments
-- Total Return year to date to 30 September 2016 was 1.3% and Total Return since IPO is 7.0%
o In Q3, Derived Debt Investments were up 3.3% and Derived
Equity Investments were up 9.1%
o In Q3, Private Equity was largely flat at -0.2% as a result of
a slowdown in underlying companies' earnings growth and a lower
valuation of AGA's holding in Apax Europe VII carried interest
Private Equity - Operational Metrics 30 September 2016 30 June 2016
Portfolio year-over-year Last Twelve Months (LTM) revenue growth(1) 6.9% 7.4%
===================================================================== ================= ============
Portfolio year-over-year LTM EBITDA growth(1) 8.1% 9.8%
===================================================================== ================= ============
Average EV/EBITDA multiple(1) 12.0x 11.9x
===================================================================== ================= ============
Average net debt / EBITDA(1) 4.3x 4.4x
===================================================================== ================= ============
Number of new investments in the quarter (2) 3 1
===================================================================== ================= ============
Number of exits in the quarter (2) 5 3
-- Private Equity portfolio highlights:
o Apax Funds have returned EUR17.2m to AGA in Q3 2016
o Unrealised losses were EUR0.8m and FX losses were EUR1.4m
o Apax VIII closed two new investments (Duck Creek Technologies
and Neuraxpharm/Invent Farma) and Apax IX closed its first
investment (Dominion Marine Media). An Apax VIII investment
previously announced during H1 2016 closed after the quarter end
(Vyaire).
o Aggregate IRR generated on fully exited investments was
36.4%(10) for the Private Equity portfolio
Derived Investments - Operational Metrics 30 September 2016 30 June 2016
Yield to maturity(3) of debt investments 12.1% 12.7%
========================================================== ================= ============
Average years to maturity for debt investments 5.4 5.6
========================================================== ================= ============
Average income yield(4) of debt investments 9.9% 10.1%
========================================================== ================= ============
Year-over-year LTM EBITDA growth debt investments(5) 2.3% 1.3%
========================================================== ================= ============
Year-over-year LTM earnings growth equity investments(6) 20.1% 18.5%
========================================================== ================= ============
Average P/E multiple(7) of equity investments 18.0x 17.9x
Number of new investments in the quarter (8) 3 5
Number of full exits in the quarter (9) 7 6
-- Derived Investments portfolio highlights:
o AGA fully exited two debt investments and five listed equity
investments, together with two partial realisations. Proceeds of
EUR60.0m were realised in the quarter.
o Income generated was EUR8.1m in the 3 months to 30 September
2016
o In Q3 2016, AGA made two new investments in debt, and one new
investment in equity totalling EUR45.7m
Commenting on AGA's investment focus, Ralf Gruss, COO of Apax
Partners, said:
"I am pleased to report that AGA's performance has improved in
Q3. The portfolio finished the quarter with a positive Total Return
of 2.0%.
AGA's investment portfolio is well diversified. While the
performance of the Private Equity portfolio was largely flat in the
quarter, AGA's Derived Investments portfolio performed strongly due
to gains in both Derived Debt and Derived Equity."
Financial highlights
Private Derived Cash Others Total
Equity Investments
EURm EURm EURm EURm EURm
Adjusted NAV at
30 June 2016 435.0 406.4 48.5 4.5 894.4
+ Investments - 45.7 (45.7) - -
- Divestments (17.2) (60.0) 79.9 (2.7) (0.0)
+ Interest and dividend
income - - 7.6 0.5 8.1
+/- Unrealised FV
movement (0.8) 17.2 - - 16.4
+/- Realised FV
movement - 2.4 - - 2.4
+/- FX losses (1.4) (3.4) (0.5) - (5.2)
+/- Costs and others - - (1.8) (1.3) (3.1)
- Dividends paid - - (22.4) - (22.4)
+/- Performance
fee reserve 1.1 (2.1) - - (1.0)
Adjusted NAV at
30 Sept 2016 416.7 406.2 65.6 1.0 889.6
Invested portfolio analysis at 30 September 2016
Asset class EURm EURm % %
Private Equity 421.0 51%
==================== ====== ====== ==== ====
* AMI 3.9 1%
==================== ====== ====== ==== ====
* AEVI 2.2 1%
==================== ====== ====== ==== ====
* AE VII 67.9 8%
==================== ====== ====== ==== ====
* AVIII 349.0 42%
==================== ====== ====== ==== ====
* AIX* (2.0) (1%)
==================== ====== ====== ==== ====
Derived Investments 409.6 49%
==================== ====== ====== ==== ====
* Debt 319.2 38%
==================== ====== ====== ==== ====
* Equities 90.4 11%
==================== ====== ====== ==== ====
Total 830.6 830.6 100% 100%
==================== ====== ====== ==== ====
*AIX value is negative as it has drawn on the capital call
facility as a bridge to the first capital call for new investments
in the fund and to pay fund start-up costs and fees.
Sector mix Invested portfolio Private Equity Derived Investments
EURm % % %
Tech & Telco 312.5 38% 37% 38%
============= ====== ================== ============== ===================
Services 203.2 24% 29% 20%
============= ====== ================== ============== ===================
Healthcare 165.0 20% 16% 24%
============= ====== ================== ============== ===================
Consumer 138.0 17% 16% 17%
============= ====== ================== ============== ===================
Other 11.9 1% 2% 1%
============= ====== ================== ============== ===================
Total 830.6 100% 100% 100%
============= ====== ================== ============== ===================
Geographic analysis Invested portfolio Private Equity Derived Investments
EURm % % %
North America 472.8 57% 45% 69%
==================== ====== ================== ============== ===================
UK 25.9 3% 3% 4%
==================== ====== ================== ============== ===================
Switzerland 15.9 2% 0% 4%
==================== ====== ================== ============== ===================
Rest of Europe 206.2 25% 39% 10%
==================== ====== ================== ============== ===================
India 75.2 9% 8% 10%
==================== ====== ================== ============== ===================
China 13.7 2% 1% 2%
==================== ====== ================== ============== ===================
Rest of World 20.9 2% 4% 1%
==================== ====== ================== ============== ===================
Total 830.6 100% 100% 100%
==================== ====== ================== ============== ===================
Summary of top 10 investments in Private Equity and Derived
Investments
Valuation NAV
EURm %
Top 10 Private Equity
============================= ==================== ====
EVRY AS 45.4 5%
============================= ==================== ====
GlobalLogic Inc 42.0 5%
============================= ==================== ====
Assured Partners Inc. 35.0 4%
============================= ==================== ====
Azelis S.A. 34.3 4%
============================= ==================== ====
Exact Software 34.1 4%
============================= ==================== ====
Wehkamp 24.4 3%
============================= ==================== ====
One Call / Align 23.6 3%
============================= ==================== ====
Full Beauty 23.3 3%
============================= ==================== ====
Shriram City Union 22.5 3%
============================= ==================== ====
Engineering 19.7 2%
============================= ==================== ====
Other 116.7 11%
============================= ==================== ====
Total Private Equity 421.0 47%
============================= ==================== ====
Top 10 Derived Investments
============================= ==================== ====
Full Beauty 31.2 3%
============================= ==================== ====
Ellucian 28.2 3%
============================= ==================== ====
Acelity 26.8 3%
============================= ==================== ====
Compuware 21.0 2%
============================= ==================== ====
Azelis S.A. 19.8 2%
============================= ==================== ====
Genex 19.3 2%
============================= ==================== ====
Assured Partners Inc. 17.6 2%
============================= ==================== ====
Rentpath 17.3 2%
============================= ==================== ====
Advantage Sales & Marketing 17.2 2%
============================= ==================== ====
Unilabs 15.4 2%
============================= ==================== ====
Other 195.8 23%
============================= ==================== ====
Total Derived Investments 409.6 46%
============================= ==================== ====
Total Investments 830.6 93%
============================= ==================== ====
Cash 65.6 6%
============================= ==================== ====
Net current assets 1.0 1%
============================= ==================== ====
Total NAV 897.2 100%
============================= ==================== ====
Performance fee reserve (7.6)
============================= ==================== ====
Total Adjusted NAV 889.6
============================= ==================== ====
Contact details
Investor Relations
Sarah Wojcik
Telephone: +44 (0)20 7872 6300
Email: investor.relations@apaxglobalalpha.com
Media enquiries (Apax Global Alpha Limited)
Georgiana Brunner/Annabel Clay, Greenbrook Communications
Telephone: +44 (0)20 7952 2000
Email: aga@greenbrookpr.com
Media enquiries (Apax Partners LLP)
Alex Wessendorff
Telephone: +44 (0)20 7872 6461
Email: alex.wessendorff@apax.com
Company Secretary
Matt Horton/Jacques Colley, Aztec Group
Telephone: +44 (0)1481 749 700
Email: AGA-Admin@aztecgroup.co.uk
Notes
1. The information presented herein is not an offer for sale
within the United States of any equity shares or other securities
of Apax Global Alpha Limited ("AGA"). AGA has not been and will not
be registered under the US Investment Company Act of 1940, as
amended (the "Investment Company Act"). In addition, AGA's shares
(the "Shares") have not been and will not be registered under the
Securities Act or any other applicable law of the United States.
Consequently, the Shares may not be offered or sold or otherwise
transferred within the United States, or to, or for the account or
benefit of, US Persons, except pursuant to an exemption from the
registration requirements of the Securities Act and under
circumstances which will not require AGA to register under the
Investment Company Act. No public offering of the Shares is being
made in the United States.
2. This announcement may include forward-looking statements. The
words "expect", "anticipate", "intends", "plan", "estimate", "aim",
"forecast", "project" and similar expressions (or their negative)
identify certain of these forward-looking statements. These
forward-looking statements are statements regarding AGA's
intentions, beliefs or current expectations concerning, among other
things, AGA's results of operations, financial condition,
liquidity, prospects, growth and strategies. The forward-looking
statements in this presentation are based on numerous assumptions
regarding AGA's present and future business strategies and the
environment in which AGA will operate in the future.
Forward-looking statements involve inherent known and unknown
risks, uncertainties and contingencies because they relate to
events and depend on circumstances that may or may not occur in the
future and may cause the actual results, performance or
achievements of AGA to be materially different from those expressed
or implied by such forward looking statements. Many of these risks
and uncertainties relate to factors that are beyond AGA's ability
to control or estimate precisely, such as future market conditions,
currency fluctuations, the behaviour of other market participants,
the actions of regulators and other factors such as AGA's ability
to continue to obtain financing to meet its liquidity needs,
changes in the political, social and regulatory framework in which
AGA operates or in economic or technological trends or conditions.
Past performance should not be taken as an indication or guarantee
of future results, and no representation or warranty, express or
implied, is made regarding future performance. AGA expressly
disclaims any obligation or undertaking to release any updates or
revisions to these forward-looking statements to reflect any change
in AGA's expectations with regard thereto or any
change in events, conditions or circumstances on which any
statement is based after the date of this announcement, or to
update or to keep current any other information contained in this
announcement. Accordingly, undue reliance should not be placed on
the forward-looking statements, which speak only as of the date of
this announcement.
Footnotes
(1) Represents the weighted average of the respective metrics
across the underlying portfolio companies, using latest available
information
(2) Represents investments and exits during the quarter ended at
the indicated date. During Q3 2016 there were 2 full closed exits
(Epicor and Trader Corporation) and 3 closed partial exits
represented by the partial secondary sales of Ascential, Capio and
Chola shares. The above number of exits excludes the
recapitalisation of Evry during Q2 2016 and Ideal Protein during Q3
2016.
(3) GAV weighted average yield to maturity (YTM) of the Derived Debt Investments
(4) GAV weighted average of the current full year income (annual
coupon/clean price as at 30 Sept 2016) for each debt position in
the Derived Debt Investments at 30 Sept 2016
(5) GAV weighted average of latest available EBITDA growth,
since prior year, of the underlying Derived Debt Investments
(6) GAV weighted average of the latest earnings growth, since
prior year, of the underlying Derived Equity Investments. Excludes
Palo Alto
(7) GAV weighted Price Earnings multiple of Derived Equity Investments
(8) New investments in debt in the 3 months to 30 Sept 2016 were
in Vertafore and Acelity and one new equity position in TAKE.
(9) Disposals in quarter ended 30 Sept 2016 consisted of debt
realisations in Berlin Packaging and Peak 10 second lien debt and
equity realisations in LIC Housing, Hinduja Global Solutions,
Alkem, Edelweiss and Smart Technologies.
(10) Returns shown represent gross returns to the Apax Funds,
i.e. AMI, Apax VIII, Apax Europe VII, Apax Europe VI. It also
includes total invested cost, total realised value to date and
unrealised value at 30 September 2016.
About Apax Global Alpha Ltd
AGA is a Guernsey registered closed-ended collective investment
scheme incorporated as a non-cellular company that listed on the
London Stock Exchange on 15 June 2015. It is regulated by the
Guernsey Financial Services Commission.
AGA's objective is to provide shareholders with capital
appreciation from its investment portfolio and regular dividends.
The Company is targeting an annualised Total Return, across
economic cycles, of 12-15% (net of fees and expenses) including a
dividend yield of 5% of Net Asset Value (NAV).
The investment policy of the Company is to make private equity
investments in Apax Funds and Derived Investments which are
investments in equities and debt derived from the insights gained
via Apax Partners' Private Equity activities. The Company's
portfolio is expected to be allocated in approximately equal
proportions between Private Equity and Derived Investments,
although the investment mix will fluctuate over time due to market
conditions, investment opportunities, cash flow requirements, the
dividend policy and other factors.
Further information regarding the Company and its publications
are available on the Company's website at
www.apaxglobalalpha.com
About Apax Partners LLP
Apax Partners LLP ("Apax Partners") is a leading global private
equity advisory firm. It operates globally and has more than 30
years of investing experience. Apax Partners has advised funds that
total over EUR40 billion in aggregate as at 30 September 2016*.
Funds advised by Apax Partners invest in companies across four
global sectors of Tech & Telco, Services, Healthcare and
Consumer. These funds provide long--term equity financing to build
and strengthen world--class companies. For further information
about Apax Partners, please visit www.apax.com.
Apax Partners LLP is authorised and regulated by the Financial
Conduct Authority in the UK.
* Funds raised since 1981, commitments converted from fund
currency to EUR at FX rates as at September 2016
This information is provided by RNS
The company news service from the London Stock Exchange
END
QRTBLBDGCSXBGLB
(END) Dow Jones Newswires
November 01, 2016 03:00 ET (07:00 GMT)
Apax Global Alpha (LSE:APAX)
Historical Stock Chart
From Apr 2024 to May 2024
Apax Global Alpha (LSE:APAX)
Historical Stock Chart
From May 2023 to May 2024